Literature DB >> 9667406

Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population.

M C Koch1, K Stegmann, A Ziegler, B Schröter, A Ermert.   

Abstract

UNLABELLED: A number of recent studies have demonstrated that the occurrence and recurrence risk of neural tube defects (NTD) is reduced by folic acid supplementation before and during pregnancy. Epidemiological studies have shown low plasma folate and raised plasma homocysteine in women with spina bifida aperta (SB) children suggesting an abnormal folate metabolism. The 5,10-methylenetetrahydrofolate reductase (MTHFR) variant C677T, resulting in a decreased activity of the enzyme, has been associated with the development of NTD. Several studies demonstrated that homozygosity for the C677T mutation occurs at a higher frequency in patients with SB phenotype than in control individuals. The SB risk is strongest if both the mother and her child have the mutation in the homozygous state. In the present study we compared the frequency of the C- and T-alleles in healthy German individuals (n = 153) with German SB patients (n = 137). Our study groups reveal no significant difference in C/T-allele frequencies and genotype distributions. A family based association study, the transmission disequilibrium test, confirms the absence of an association between T-allele and SB. In 9 of 40 families we were able to exclude linkage to the MTHFR locus (1p36.3) employing different inheritance models.
CONCLUSION: Our data show no evidence for an association between the C677T mutation and the occurrence of the SB phenotype. Therefore we cannot support the hypothesis that the MTHFR variant does account for a significant genetic predisposition to the SB phenotype in the studied German patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667406     DOI: 10.1007/s004310050860

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

Review 1.  Current perspectives on the genetic causes of neural tube defects.

Authors:  Patrizia De Marco; Elisa Merello; Samantha Mascelli; Valeria Capra
Journal:  Neurogenetics       Date:  2006-08-29       Impact factor: 2.660

2.  The "thermolabile" variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother.

Authors:  D C Shields; P N Kirke; J L Mills; D Ramsbottom; A M Molloy; H Burke; D G Weir; J M Scott; A S Whitehead
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

3.  A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group.

Authors:  Lawrence C Brody; Mary Conley; Christopher Cox; Peadar N Kirke; Mary P McKeever; James L Mills; Anne M Molloy; Valerie B O'Leary; Anne Parle-McDermott; John M Scott; Deborah A Swanson
Journal:  Am J Hum Genet       Date:  2002-10-16       Impact factor: 11.025

4.  Folate receptor 1 is necessary for neural plate cell apical constriction during Xenopus neural tube formation.

Authors:  Olga A Balashova; Olesya Visina; Laura N Borodinsky
Journal:  Development       Date:  2017-03-02       Impact factor: 6.868

5.  MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-analysis.

Authors:  Jinyu Zheng; Xiaocheng Lu; Hao Liu; Penglai Zhao; Kai Li; Lixin Li
Journal:  Neurol Sci       Date:  2014-12-13       Impact factor: 3.307

6.  MTHFR 677TT genotype increases the risk for cervical artery dissections.

Authors:  M Kloss; T Wiest; S Hyrenbach; I Werner; M-L Arnold; C Lichy; C Grond-Ginsbach
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-08       Impact factor: 10.154

7.  Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability.

Authors:  Luciano Delgado-Plasencia; Vicente Medina-Arana; Alberto Bravo-Gutiérrez; Julián Pérez-Palma; Hugo Álvarez-Argüelles; Eduardo Salido-Ruiz; Antonia M Fernández-Peralta; Juan J González-Aguilera
Journal:  Int J Colorectal Dis       Date:  2013-02-20       Impact factor: 2.571

Review 8.  Folate action in nervous system development and disease.

Authors:  Olga A Balashova; Olesya Visina; Laura N Borodinsky
Journal:  Dev Neurobiol       Date:  2018-02-06       Impact factor: 3.964

9.  [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase.

Authors:  R Prinz-Langenohl; S Brämswig; O Tobolski; Y M Smulders; D E C Smith; P M Finglas; K Pietrzik
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

10.  Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies.

Authors:  Lifeng Yan; Lin Zhao; Yan Long; Peng Zou; Guixiang Ji; Aihua Gu; Peng Zhao
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.